GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.
Related Posts
Auto & Transport Roundup: Market Talk
Find insight on the impact of planned U.S. tariffs, Singapore Post and more in the latest Market Talks covering the Auto and Transport sector.
TUI Shares Slip on Slower Growth Expectations
The travel operator guided for a lower rate of growth in the current fiscal year, despite posting a jump in profit for fiscal 2024 on […]
Pfizer’s Strong Quarter Bolsters CEO’s Comeback Efforts
The pharmaceutical company reported its third consecutive quarter with positive results.